Effect of nitric oxide synthase inhibitor on age-related changes in second messenger systems and calcium channels in rats

Metabolic Brain Disease

Volumn 12, Issue 1, 1997, Pages 83-92

  Araki, T ^a   Kato, H ^a   Shuto, K ^b   Fujiwara, T ^c   Itoyama, Y ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Tanabe Co Ltd   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Aging; autoradiography; calcium channels; forskolin; N(G) nitro L arginine methyl ester; nitric oxide synthase; protein kinase C; rolipram

Indexed keywords

CALCIUM CHANNEL; FORSKOLIN; ISRADIPINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL DIBUTYRATE; PHOSPHODIESTERASE; PROTEIN KINASE C; ROLIPRAM;

ADOLESCENT; AGED; AGING; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; HIPPOCAMPUS; MALE; NONHUMAN; RAT; SECOND MESSENGER; SUBSTANTIA NIGRA; THALAMUS;

EID: 0030905484     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02676356     Document Type: Article

References (29)

1. Araki, T., Kato, H. and Kogure, K. (1991). Postischemic alteration of muscarinic acetylcholine, adenosine A1 and calcium antagonist binding sites in selectively vulnerable areas: an autoradiographic study of gerbil brain. J. Neurol. Sci. 106:206-212.
2. Araki, T., Kato, H. and Kogure, K. (1992). Mapping of second messenger and rolipram receptors in mammalian brain. Brain Res. Bull. 28:843-848.
3. Araki, T., Kato, H., Kanai, Y. and Kogure, K. (1994). Age-dependent changes in second messenger and rolipram receptor systems in the gerbil brain. J. Neural Transm. 97:135-147.
4. Araki, T., Kato, H., Fujiwara, T. and Itoyama, Y. (1995). Age-related changes in bindings of second messengers in the rat brain. Brain Res. 704:227-232.
5. Boulton, C.L., Irving, A.J., Southam, E., Potier, B., Garthwaite, J. and Collingridge, G.L. (1994). The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci. 6:1528-1535.
6. Bredt, D.S., Ferris, C.D. and Snyder, S.H. (1992). Nitric oxide synthase regulatory sites. J. Biol. Chem. 267:10976-10981.
7. Bredt, D.S. and Snyder, S.H. (1994). Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem. 63:175-195.
8. Daniel, H., Hermart, N., Jailard, D. and Crepel, F. (1993). Long-term depression requires nitric oxide and guanosine 3′:5′ cyclic monophosphate production in rat cerebellum. Eur. J. Neuosci. 5:1079-1082.
9. Dawson, T.M. and Snyder, S.H. (1994). Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:5147-5159.
10. Durieu-Trautmann, O., Federici, C., Creminon, C., Foignant-Chaverot, N., Roux, F., Claire, M., Strosberg, A.D. and Couraud, P.O. (1993). Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J. Cell. Physiol. 155:104-111.
11. Hernández, F., Alexander, S.P.H. and Kendall, D.A. (1994). Forskolin and 3-isobutyl-methylxanthine increases basal and sodium nitroprusside-elevated cyclic GMP levels in adult guinea-pig cerebellar slices. J. Neurochem. 62:2212-2218.
12. Iadecola, C., Pelligrino, D.A., Moskowitz, M.A. and Lassen, N.A. (1994). State of the art review: nitric oxide synthase inhibition and cerebrovascuiar regulation. J. Cereb. Blood Flow Metab. 14:175-192.
13. Ignarrro, L.J. (1990). Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann. Rev. Pharmacol. Toxicol. 30:535-560.
14. 3H]rolipram. Brain Res. 503:229-245.
15. G-nitroarginine binding in rat brain. Neuropharmacology 34:63-73.
16. Kuluz, J.W., Prado, R.J., Dietrich, W.D., Schleien, C.L. and Watson, B.D. (1993). The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24:2023-2029.
17. Lonart, G., Wang, J. and Johanson, K.M. (1992). Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol. 220:271-272.
18. 3H]glutamate by striatal synaptosomes. J. Neurochem. 63:2108-2117.
19. Marletta, M.A. (1994). Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78:927-930.
20. 2+-independent synaptic vesicle release. Neuron 12:1235-1244.
21. Moncada, S., Palmer, R.M. and Higgs, E.A. (1991). Nitric oxide: physiology, pathology and pharmacology. Pharmacol. Rev. 43:109-142.
22. Nathan, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
23. Nathan, C. and Xie, Q.W. (1994). Nitric oxide synthases: roles, tolls, and control. Cell 78:915-918.
24. Pelligrino, D.A. (1993). Editorial: saying NO to cerebral ischemia. J. Neurosurg. Anesthesiol. 5:221-231.
25. Prast, H. and Philippu, A. (1992). Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol. 216:139-140.
26. 2+ release from internal stores in neuronal cell line is enhanced by cyclic AMP. Eur. J. Pharmacol. 227:89-93.
27. Scott-Burden, T., Elizondo, E., Ge, T., Boulanger, C.M. and Vanhoutte, P.M. (1994). Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol. Pharmacol. 46:274-282.
28. Shibuki, K. and Okada, D. (1991). Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349:326-328.
29. Zhu, X.-Z. and Luo, L.-G. (1992). Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59:932-935.